PFG
50
-2
HST
59
7
SNA
65
-3
PSA
63
2
VFC
50
-2
NVDA
54
2
UAL
83
-2
EW
46
3
V
72
-4
LB
60
4
EMC
56
-3
LH
45
-3
GILD
54
3
CF
56
3
UA
57
-8
SLG
64
-2
LEG
43
-7
XRX
42
-3
DUK
64
7
C
62
-3
PFG
50
-2
HST
59
7
SNA
65
-3
PSA
63
2
VFC
50
-2
NVDA
54
2
UAL
83
-2
EW
46
3
V
72
-4
LB
60
4
EMC
56
-3
LH
45
-3
GILD
54
3
CF
56
3
UA
57
-8
SLG
64
-2
LEG
43
-7
XRX
42
-3
DUK
64
7
C
62
-3
Financhill
Back

BNY Mellon Emerging Markets Equity ETF Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
54

BKEM
BNY Mellon Emerging Markets Equity ETF

Last Price:
59.79
Seasonality Move:
6.35%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
136.74
Seasonality Move:
14.88%
Buy
54
BNY Mellon Emerging Markets Equity ETF (BKEM) is a Buy

Is BNY Mellon Emerging Markets Equity ETF a Buy, Sell or Hold?

  • The current BNY Mellon Emerging Markets Equity ETF [BKEM] share price is $59.94. The Score for BKEM is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • BKEM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BKEM Stock Price Chart

What is BNY Mellon Emerging Markets Equity ETF's stock price today?

  • The BNY Mellon Emerging Markets Equity ETF share price today is $59.94
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BKEM is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

BKEM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.64 Sell
Relative Strength Index (14 RSI): 40.16 Sell
Chaikin Money Flow: -1651 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (60 - 62.24) Sell
Bollinger Bands (100): (59.09 - 63.01) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

BKEM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 60.05 Sell
20-day SMA: 60.81 Sell
50-day SMA: 62.32 Sell
200-day SMA: 59.59 Buy
8-day EMA: 60.18 Sell
20-day EMA: 60.76 Sell
50-day EMA: 61.33 Sell
200-day EMA: 59.69 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

BNY Mellon Emerging Markets Equity ETF Earnings Growth & BKEM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

BNY Mellon Emerging Markets Equity ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):